---
title: Recurrent Intracranial Ewing Sarcoma
date: '2024-09-16'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39280867/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240917194252&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'Background: Ewing sarcoma is a rare malignant neoplasm that is primarily
  localized in bone tissues. The prognosis for patients with a newly diagnosed localized
  Ewing sarcoma has been greatly improved by multimodality treatment. However, treating
  patients with disseminated or recurrent disease is challenging, with a 5-year overall
  survival rate of <30%. Case Report: A 17-year-old female with an asymptomatic tumor
  of the left temple underwent 3 cycles of vincristine, ifosfamide, doxorubicin, ...'
disable_comments: true
---
Background: Ewing sarcoma is a rare malignant neoplasm that is primarily localized in bone tissues. The prognosis for patients with a newly diagnosed localized Ewing sarcoma has been greatly improved by multimodality treatment. However, treating patients with disseminated or recurrent disease is challenging, with a 5-year overall survival rate of <30%. Case Report: A 17-year-old female with an asymptomatic tumor of the left temple underwent 3 cycles of vincristine, ifosfamide, doxorubicin, ...